港股收評:三大指數齊跌 科技股分化 消費股集體活躍 汽車股繼續下跌
港股三大指數集體下跌,呈現高開低走行情,市場表現平淡。截止收盤,恒生指數、國企指數分別下跌0.53%及0.31%,恒生科技指數跌0.15%。盤面上,大型科技股升跌各異,快手績後升近6%,網易升近3%,小米勉強飄紅,阿里巴巴跌近2%,京東、騰訊跌超1%;政策持續發力,三胎概念股走勢活躍,嬰童概念股、乳製品股升幅明顯;阿里影業持續大升帶動影視股上升,啤酒股、餐飲股、體育用品股等消費概念齊升。另一方面,汽車股跌勢不止,比亞迪股份、理想汽車跌超2.5%,半導體股全天低迷,龍頭中芯國際跌2.5%,連續上升的生物醫藥股回調。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.